coylePresented by:

Joseph R. Berger, MD, MPH
Perelman School of Medicine, University of Pennsylvania

Patricia K. Coyle, MD
Stony Brook University

This activity is no longer available for credit.


CME/CE Information

Activity Title Emerging Therapies and New Approaches to MS Management
Topic Multiple Sclerosis
Accreditation Type AMA PRA Category 1 Credits™
Release Date July 2015
Expiration Date July 31, 2016– No longer available for credit
Estimated Time to Complete Activity 30 minutes



Upon completion of the activity, participants should be able to:

  • Create individualized management strategies for patients with multiple sclerosis using information on the safety, efficacy, and tolerability of both established and emerging therapies
  • Review recommendations and expert opinion regarding timely and effective monitoring of multiple sclerosis activity and progression


Joseph R. Berger, MD, MPH
Professor and Chief of the MS Division
Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania

Patricia K. Coyle, MD
Professor of Neurology and Vice Chair of Clinical Affairs
Director, MS Comprehensive Care Center
Stony Brook University
Stony Brook, New York


  1. There are no fees for participating in and receiving credit for this activity.
  2. Review the activity objectives and CME information.
  3. Complete the CME activity.
  4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
  5. Complete the CME evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  6. Your CME certificate will be available for download.


This site is best viewed using Internet Explorer 8.0 or higher, Google Chrome 29.0 or higher, Firefox 4.0 or higher. For interactive content, a broadband connection is required. For all CME/CNE activities featuring audio you must have a sound card and speakers.

Our interactive activities may require the Adobe Flash Player (available from the Adobe Web site) and Adobe Shockwave Player (available from the Adobe Web site). Both browser plug-ins are free.

Our activities may require JavaScript to be enabled on your computer.


This activity is provided by The France Foundation in partnership with the Consortium of Multiple Sclerosis Centers.


The target audience for this activity includes neurologists, nurses, nurse practitioners, physician assistants, rehabilitation professionals, case managers, and others involved in the management of patients with MS.


There is a need for improved clinician consensus and consistency with regard to monitoring MS patients and assessing disease progression.


The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The France Foundation designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provided by The France Foundation in partnership with the Consortium of Multiple Sclerosis Centers.


In accordance with the ACCME Standards for Commercial Support of CME, The France Foundation implemented mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.


It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation identified and resolved any and all conflicts of interest prior to the release of this activity.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, or other members at the Consortium of Multiple Sclerosis Centers who control content have no relevant financial relationships to disclose.

Faculty Disclosure

The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:

  • Joseph Berger, MD, MPH, has served as a consultant for Amgen, Astra Zeneca, Bristol Myers Squibb, Eisai, Janssen, Millenniuim, Parexel, Pfizer, Roche, Takeda, Genetech, Genzyme, Incyte, Inhibikase, Johnson & Johnson, and Novartis and has received grants/research support from Biogen.
  • Patricia K. Coyle, MD, has received grants/research support from Actelion, Novartis, and Opexa. She has served as a consultant to AbbVie, Accordant, Acorda, Bayer, Biogen, Genentech/Roche, Genzyme/Sanofi, Novartis, Serono, and Teva.


The France Foundation requires CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.


Supported by educational grant from Mylan, Inc.


The France Foundation and the Consortium of Multiple Sclerosis Centers present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, the Consortium of Multiple Sclerosis Centers and Mylan, Inc assume no liability for the information herein.


Copyright © 2015 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.


The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at


If you have questions about this CME/CNE activity, please contact The France Foundation at 860-434-1650 or This email address is being protected from spambots. You need JavaScript enabled to view it..


Latest CME/CNE Education

  • Advances in MS Assessment: Biomarkers and Imaging

    Read More
  • Defining the Clinical Course of Multiple Sclerosis

    Read More
  • Partners in Care: Engaging Patients With Shared Decision-Making Strategies and the Comprehensive Care Team

    Read More